Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 08/31/16
Due: 08/31/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| CPCT-05 Biopsy Protocol Patient Selection | NCT01904916 | P.O. Witteveen | user2@example.com | None | 2014-01-31 | 2017-03-31 | 2018-03-31 | - | - | 2025-07-14 |
| Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma | NCT00827671 | P.O. Witteveen | user2@example.com | None | 2009-03-31 | 2016-03-31 | 2017-03-31 | - | - | 2025-07-14 |
| Biomarker Development for Response Prediction by DNA Mutational Analysis | NCT01855061 | P.O. Witteveen | user2@example.com | None | 2011-05-31 | 2016-08-31 | 2017-08-31 | - | - | 2025-07-14 |